• / Free eNewsletters & Magazine
  • / My Account
Home>Biotech IPOs: What to Learn from a Banner Year

Biotech IPOs: What to Learn from a Banner Year

Perspectives Content Submission

Thu, 23 Jan 2014

Published with permission from  Knowledge @ Wharton , Wharton’s online business journal. The data is in, and there is no question that 2013 was the most active year for biotechnology initial public offerings since 2000. During the 12 months ended in December, 38 biotech companies debuted on Wall St

Related Videos

  1. Danoff, Davis, Lynch: Stock-Picking Ahead of the Crowd

    The past Morningstar Manager of the Year winners favor credit card firms, split views on Facebook, address China's importance, extol executives' foresight for future growth and disruption, and much more in this panel presentation at the Morningstar Investment Conference.

  2. Top Biotech Acquisition Candidates

    2011 was a relatively light year for biotech M&A, but it looks like activity is picking up in 2012.

©2017 Morningstar Advisor. All right reserved.